Literature DB >> 22815418

The diagnostic value of FDG-PET cannot be judged by iliac bone marrow biopsy.

G Cheng.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22815418      PMCID： PMC3587095          DOI： 10.1259/bjr/61638269

Source DB:  PubMed          Journal:  Br J Radiol        ISSN： 0007-1285            Impact factor:   3.039


× No keyword cloud information.
  17 in total

1.  Diagnostic utility of bilateral bone marrow examination: significance of morphologic and ancillary technique study in malignancy.

Authors:  Jun Wang; Lawrence M Weiss; Karen L Chang; Marilyn L Slovak; Karl Gaal; Stephen J Forman; Daniel A Arber
Journal:  Cancer       Date:  2002-03-01       Impact factor: 6.860

2.  Bone involvement in patients with lymphoma: the role of FDG-PET/CT.

Authors:  Niklaus G Schaefer; Klaus Strobel; Christian Taverna; Thomas F Hany
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-09-22       Impact factor: 9.236

3.  Expert opinions on positron emission tomography and computed tomography imaging in lymphoma.

Authors:  Dominique Delbeke; Sigrid Stroobants; Eric de Kerviler; Christian Gisselbrecht; Michel Meignan; Peter S Conti
Journal:  Oncologist       Date:  2009

4.  Value of bilateral bone marrow biopsy specimens in non-Hodgkin's lymphoma.

Authors:  S K Juneja; M M Wolf; I A Cooper
Journal:  J Clin Pathol       Date:  1990-08       Impact factor: 3.411

5.  Revised response criteria for malignant lymphoma.

Authors:  Bruce D Cheson; Beate Pfistner; Malik E Juweid; Randy D Gascoyne; Lena Specht; Sandra J Horning; Bertrand Coiffier; Richard I Fisher; Anton Hagenbeek; Emanuele Zucca; Steven T Rosen; Sigrid Stroobants; T Andrew Lister; Richard T Hoppe; Martin Dreyling; Kensei Tobinai; Julie M Vose; Joseph M Connors; Massimo Federico; Volker Diehl
Journal:  J Clin Oncol       Date:  2007-01-22       Impact factor: 44.544

6.  A large-scale study of bone marrow involvement in patients with Hodgkin's lymphoma.

Authors:  Alessandro Levis; Daniela Pietrasanta; Laura Godio; Umberto Vitolo; Giorgio Ciravegna; Francesco Di Vito; Paolo Gavarotti; Tommasina Guglielmelli; Lorella Orsucci; Ermanno Raviolo; Delia Rota Scalabrini; Flavia Salvi; Anna Tonso; Massimo Aglietta; Mario Boccadoro; Andrea Gallamini; Giuseppe Saglio; Enzo Scassa; Eugenio Gallo
Journal:  Clin Lymphoma       Date:  2004-06

7.  Bilateral trephine bone marrow biopsies in Hodgkin's and non-Hodgkin's lymphoma.

Authors:  N C Menon; J G Buchanan
Journal:  Pathology       Date:  1979-01       Impact factor: 5.306

8.  Prospective study of bone marrow infiltration in aggressive lymphoma by three independent methods: whole-body MRI, PET/CT and bone marrow biopsy.

Authors:  Vincent Ribrag; Daniel Vanel; Sophie Leboulleux; Jean Lumbroso; Dominique Couanet; Guillaume Bonniaud; Anne Aupérin; Florence Masson; Jacques Bosq; Véronique Edeline; Christophe Fermé; Frédéric Pigneur; Martin Schlumberger
Journal:  Eur J Radiol       Date:  2007-07-24       Impact factor: 3.528

9.  The utility of 18-F-fluorodeoxyglucose positron emission tomography in evaluation of bone marrow involvement by non-Hodgkin lymphoma.

Authors:  Alaa A Muslimani; Hany L Farag; Smitha Francis; Timothy P Spiro; Asif A Chaudhry; Vincent C Chan; Harris C Taylor; Hamed A Daw
Journal:  Am J Clin Oncol       Date:  2008-10       Impact factor: 2.339

10.  Positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose for initial staging of hodgkin lymphoma: a single center experience in Brazil.

Authors:  Juliano Julio Cerci; Luís Fernando Pracchia; José Soares Junior; Camila da Cruz Gouveia Linardi; José Claudio Meneghetti; Valeria Buccheri
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365
View more
  1 in total

1.  Critical considerations on the combined use of ¹⁸F-FDG and ¹⁸F-fluoride for PET assessment of metastatic bone disease.

Authors:  Gang Cheng; Thomas C Kwee; Sandip Basu; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-05-22       Impact factor: 9.236
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.